Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson’s disease

• Published in: Clinical autonomic research 2020-06, Vol.30 (3), p.223-230
• Main Authors: Sklerov, Miriam, Shih, Chia-Hao, Browner, Nina, Palma, Jose-Alberto, Styner, Martin, Dayan, Eran
• Format: Article
• Language: English
• Subjects: Activities of daily living; Autonomic nervous system; Cardiology; Cognitive ability; Diabetes; Endocrinology; Gastroenterology; Medical treatment; Medicine; Medicine & Public Health; Mental depression; Movement disorders; Neurodegenerative diseases; Neurology; Ophthalmology; Parkinson's disease; Research Article
• ISSN: 0959-9851; 1619-1560
• DOI: 10.1007/s10286-020-00672-7

Purpose The primary objective of this study was to examine the relationship of longitudinal changes in autonomic symptom burden and longitudinal changes in activities of daily living (ADLs); a secondary analysis examined the impact of depressive symptoms in this relationship. Methods Data were retrieved from the Parkinson’s Progression Markers Initiative (PPMI), a dataset documenting the natural history of newly diagnosed Parkinson’s disease (PD). The analysis focused on data from baseline, visit 6 (24 months after enrollment), and visit 12 (60 months after enrollment). The impact of longitudinal changes in autonomic symptom burden on longitudinal changes in ADLs function was examined. A secondary mediation analysis was performed to investigate whether longitudinal changes in depressive symptoms mediate the relationship between longitudinal changes in autonomic symptom burden and ADLs function. Results Changes in autonomic symptom burden, cognitive function, depressive symptoms, and motor function all correlated with ADLs. Only changes in ADLs and depression were found to be associated with changes in autonomic symptom burden. We found that longitudinal change in autonomic symptoms was a significant predictor of change in ADLs at 24 and 60 months after enrollment, with the cardiovascular subscore being a major driver of this association. Mediation analysis revealed that the association between autonomic symptoms and ADLs is partially mediated by depressive symptoms. Conclusions Longitudinal changes in autonomic symptoms impact ADLs function in patients with early signs of PD, both directly and indirectly through their impact on depressive symptoms. Future investigation into the influence of treatment of these symptoms on outcomes in PD is warranted.